WST - West Pharmaceutical Services, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Total Revenue 1,717,400 1,599,100 1,509,100 1,399,800
Cost of Revenue 1,172,000 1,086,200 1,007,700 944,000
Gross Profit 545,400 512,900 501,400 455,800
Operating Expenses
Research Development 40,300 39,100 36,800 34,100
Selling General and Administrative 256,200 242,900 238,000 233,000
Non Recurring - - - -
Others -2,000 -10,400 -2,300 48,200
Total Operating Expenses 1,466,500 1,357,800 1,280,200 1,269,700
Operating Income or Loss 250,900 241,300 228,900 130,100
Income from Continuing Operations
Total Other Income/Expenses Net -2,600 -9,700 -30,900 -8,200
Earnings Before Interest and Taxes 250,900 241,300 228,900 130,100
Interest Expense -8,400 -7,800 -8,100 -14,100
Income Before Tax 248,300 231,600 198,000 121,900
Income Tax Expense 41,400 80,900 54,400 26,300
Minority Interest - - - -
Net Income From Continuing Ops 206,900 150,700 143,600 95,600
Non-recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect Of Accounting Changes - - - -
Other Items - - - -
Net Income
Net Income 206,900 150,700 143,600 95,600
Preferred Stock And Other Adjustments - - - -
Net Income Applicable To Common Shares 206,900 150,700 143,600 95,600